Literature DB >> 24796770

Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system.

Hae Min Kang1, Sung Chul Lee.   

Abstract

BACKGROUND: To evaluate the long-time progression of retinal vasculitis in Behçet patients using the fluorescein angiography (FA) scoring system.
METHODS: Retrospective study was conducted for 71 eyes of 43 patients who met the study criteria. All patients completed at least 2 years of follow-up. FA was taken during the periods of active retinal vasculitis and the quiescent phase, and analyzed using a FA scoring system. Among nine categories, the four most prevalent FA signs were evaluated: optic disc hyperfluorescence (score 0-3), macular edema (score 0-4), retinal vascular staining and/or leakage (score 0-7), and capillary leakage (score 0-10).
RESULTS: Mean number of total active inflammations was 2.6 ± 1.5 times during mean 55.0 ± 20.0 months. Mean scores at the first active inflammation were 1.8 ± 1.0 for optic disc hyperfluorescence, 2.4 ± 1.0 for macular edema, 5.3 ± 2.1 for retinal vascular staining and/or leakage, and 5.8 ± 3.2 for capillary leakage. Mean total FA score was 17.4 ± 6.8. Mean scores at the first quiescent phase were 0.6 ± 0.4 for optic disc hyperfluorescence, 1.1 ± 1.2 for macular edema, 3.8 ± 1.9 for retinal vascular staining and/or leakage, and 3.5 ± 3.5 for capillary leakage. Mean total FA score was 9.1 ± 5.0. Mean scores for each active inflammation and quiescent phase were not significantly changed, and mean FA scores were significantly reduced in quiescent phase (P = 0.003 for optic disc hyperfluorescence, P = 0.005 for macular leakage, P = 0.010 for retinal vascular staining and/or leakage, P = 0.008 for capillary leakage, and P = 0.018 for total FA score; paired t-test).
CONCLUSIONS: Retinal vasculitis of Behçet patients did not significantly progress during long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24796770     DOI: 10.1007/s00417-014-2637-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

Review 1.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  Current concepts in the etiology and treatment of Behçet disease.

Authors:  Cem Evereklioglu
Journal:  Surv Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 6.048

3.  [Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany -- current pathogenetic concepts and therapeutic possibilities].

Authors:  Andreas Altenburg; Nestor Papoutsis; Helmut Orawa; Peter Martus; Lothar Krause; Christos C Zouboulis
Journal:  J Dtsch Dermatol Ges       Date:  2006-01       Impact factor: 5.584

Review 4.  Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.

Authors:  H Yazici; C G Barnes
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

6.  Treatment and visual prognosis in Behçet's disease.

Authors:  D Benezra; E Cohen
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

7.  Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.

Authors:  Christoph M E Deuter; Manfred Zierhut; Antje Möhle; Reinhard Vonthein; Nicole Stöbiger; Ina Kötter
Journal:  Arthritis Rheum       Date:  2010-09

Review 8.  Behçet's disease.

Authors:  R C Wong; C N Ellis; L A Diaz
Journal:  Int J Dermatol       Date:  1984 Jan-Feb       Impact factor: 2.736

9.  Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.

Authors:  H Yazici; Y Tüzün; H Pazarli; S Yurdakul; Y Ozyazgan; H Ozdoğan; S Serdaroğlu; M Ersanli; B Y Ulkü; A U Müftüoğlu
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  5 in total

1.  Posterior segment inflammatory outcomes assessed using fluorescein angiography in the STOP-UVEITIS study.

Authors:  Mohammad Ali Sadiq; Muhammad Hassan; Rubbia Afridi; Muhammad Sohail Halim; Diana V Do; Yasir J Sepah; Quan Dong Nguyen
Journal:  Int J Retina Vitreous       Date:  2020-10-06

2.  Evaluation of efficacy of infliximab for retinal vasculitis and extraocular symptoms in Behçet disease.

Authors:  Akihiko Umazume; Takeshi Kezuka; Yoshihiko Usui; Jun Suzuki; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2018-03-26       Impact factor: 2.447

3.  Behçet's Uveitis: Current Diagnostic and Therapeutic Approach

Authors:  Pınar Çakar Özdal
Journal:  Turk J Ophthalmol       Date:  2020-06-27

Review 4.  Advances and potential new developments in imaging techniques for posterior uveitis Part 2: invasive imaging methods.

Authors:  Carl P Herbort; Ilknur Tugal-Tutkun; Alessandro Mantovani; Piergiorgio Neri; Moncef Khairallah; Ioannis Papasavvas
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

5.  Evaluation and Comparison of Choroidal Thickness in Patients with Behçet Disease with versus without Ocular Involvement.

Authors:  Seyedeh Maryam Hosseini; Negar Morrovatdar; Armin Hemati; Mozghan Dolatkhah; Elham Bakhtiari; Zahra Mirfeizi; Mahdieh Azimizadeh
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.